About Caplin Steriles
Caplin Steriles is a Healthcare company based in Chennai (India) founded in 2019. Developer and manufacturer of injectable products in vials, vyophilized vials and ophthalmic drops. Caplin Steriles has raised $30.65 million across 1 funding round from investors including Eight Roads Ventures and F-Prime Capital. The company has 1,003 employees. Its Indian entity Caplin Steriles Limited reported revenue of ₹377 Cr. Caplin Steriles offers products and services including Phenylephrine HCL Injection, Glycopyrrolate Injection, Sodium Nitroprusside Injection, Verapamil Hydrochloride Injection, and Ropivacaine Hydrochloride Injection. Its focus areas include Diversified Pharmaceuticals.
Company details
Caplin Steriles was founded in 2019 and is based in Chennai, India. Operations are centered in the pharmaceutical sector, where injectable products are developed and manufactured. Focus is placed on vials, lyophilized vials, and ophthalmic drops. The company maintains a domain at caplinsteriles.net for its activities, supporting production in this specialized field.
- Headquarters Chennai, India
- Employees 1,003
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website caplinsteriles.net
- Social LinkedIn
- Legal Name Caplin Steriles Limited
- Date of Incorporation 12 Dec, 2018
- Jurisdiction Chennai, Tamil Nadu, India
- Annual Revenue₹377 Cr
FY 2025 · +18% YoY
- Net Profit₹48.92 Cr
FY 2025 · 13% margin
- EBITDA₹116 Cr
FY 2025 · 31% margin
- Total Equity Funding$30.65M (USD)
in 1 rounds
- Latest Funding Round$30.65M (USD), Series C
Jan 2019
- InvestorsEight Roads Ventures
& 1 more
- Employee Count1,003
Associated legal entities of Caplin Steriles
Caplin Steriles operates through Caplin Steriles Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Caplin Steriles Limited CIN U24304TN2018PLC126270 | Active | 12 Dec 2018 | Chennai, Tamil Nadu | ₹377 Cr | 1,003 | 9 | View details |
Products & Services of Caplin Steriles
Caplin Steriles offers a comprehensive portfolio of products and services, including Phenylephrine HCL Injection, Glycopyrrolate Injection, Sodium Nitroprusside Injection, Verapamil Hydrochloride Injection, and Ropivacaine Hydrochloride Injection.
Medical injection for treating nasal congestion and hypotension.
Injection used for reducing secretions in surgical procedures.
Injection for managing hypertensive emergencies and heart failure.
Injection to treat arrhythmias and high blood pressure.
Local anesthetic injection for pain management during surgery.
Injection to prevent bleeding in surgical and traumatic situations.
Funding Insights of Caplin Steriles
Caplin Steriles has successfully raised a total of $30.65M through 1 strategic funding round. The most recent funding activity was a Series C round of $30.65 million completed in January 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $30.65M
- Total Rounds 1
- Last Round Series C — $30.65M
- First Round $30.65M
(Jan 2019)
- Investors Count 2
All 1 funding rounds of Caplin Steriles with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2019 | $30.65M | Series C | – | Eight Roads Ventures, F-Prime Capital | – |
2 investors in total: 2 institutional.
Investors in Caplin Steriles
Caplin Steriles has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Eight Roads Ventures and F-Prime Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investment and global platform support for startups. | 2008 | eightroads.com | London, United Kingdom | |
Investments in life sciences, technology, healthtech, and crypto sectors from global locations. | fprimecapital.com |
Investor details for Caplin Steriles
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Caplin Steriles Limited (Caplin Steriles)
Caplin Steriles Limited is the primary company behind Caplin Steriles. The board of Caplin Steriles Limited currently have 8 directors; the longest-serving is Partheeban Vivek Siddarth, appointed in 2018. 13 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Partheeban Vivek Siddarth DIN 02507289 | Director | 12 Dec 2018 | 7 yrs 10 mo | Caplin Steriles Limited |
| Paarthipan Chingelput Chellappan DIN 01218784 | Director | 12 Dec 2018 | 7 yrs 10 mo | Caplin Steriles Limited |
| Prem Venkatachalam Pavoor DIN 05268309 | Nominee Director | 07 Mar 2019 | 7 yrs 7 mo | Caplin Steriles Limited |
| Komattu Chacko John DIN 01067374 | Director | 08 Aug 2019 | 7 yrs 2 mo | Caplin Steriles Limited |
| Gariyali Chanderkanta DIN 08711546 | Director | 04 Mar 2020 | 6 yrs 7 mo | Caplin Steriles Limited |
| Sridhar Ganesan DIN 06819026 | Whole-time director | 13 Jun 2022 | 4 yrs 4 mo | Caplin Steriles Limited |
| Rengaraj Viswanathan DIN 07173713 | Director | 04 Jul 2023 | 3 yrs 3 mo | Caplin Steriles Limited |
| Ketan Mahendra Patel DIN 07229648 | Nominee Director | 02 Nov 2023 | 2 yrs 11 mo | Caplin Steriles Limited |
Financials of Caplin Steriles
Figures of Caplin Steriles Limited, the primary company behind Caplin Steriles, for FY 2025. Revenue was ₹377 Cr (+18% year on year). Net profit was ₹48.92 Cr (13% margin). EBITDA was ₹116 Cr (31% margin). Revenue has grown at a compounded annual rate of +43% over three years and +39% over five years.
- ₹377 CrRevenue · FY 2025 · +18% YoY
- ₹48.92 CrNet profit · 13% margin
- ₹116 CrEBITDA · 31% margin
- ₹180 CrPaid-up capital
- 1,003Employees (provident fund records)
- +43%Revenue CAGR, 3 years
- +39%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Caplin Steriles Limited are on its company page.
Detailed financial statements for Caplin Steriles
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Caplin Steriles
2 dated milestones of Caplin Steriles, from founding to its latest funding, stage changes and deals.
- Founded Caplin Steriles is founded.
- Funding First funding round of $30.6M.
Web traffic of Caplin Steriles
The website of Caplin Steriles (caplinsteriles.net) receives about 1.2K visits a month.
- Monthly visits1.2K
▲ 21.8% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Caplin Steriles
Complete news archive for Caplin Steriles
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Caplin Steriles
Caplin Steriles was founded in 2019.
Caplin Steriles is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Caplin Steriles is a funded company, having raised a total of $30.65M across 1 funding round to date. The company's 1st funding round was a Series C of $30.65M, raised on Jan 2019.
Caplin Steriles has 1,003 employees.
The primary company behind Caplin Steriles, Caplin Steriles Limited, reported revenue of ₹377 Cr for FY 2025, up 18% year on year.
Caplin Steriles was founded in 2019 and is based in Chennai, India. Operations are centered in the pharmaceutical sector, where injectable products are developed and manufactured. Focus is placed on vials, lyophilized vials, and ophthalmic drops. The company maintains a domain at caplinsteriles.net for its activities, supporting production in this specialized field.
Caplin Steriles offers Phenylephrine HCL Injection, Glycopyrrolate Injection, Sodium Nitroprusside Injection, Verapamil Hydrochloride Injection, and 2 more products and services.
Caplin Steriles has 2 investors. Key investors include Eight Roads Ventures, and F-Prime Capital.
Caplin Steriles operates through Caplin Steriles Limited.
The legal entities of Caplin Steriles currently have 9 directors, including Komattu Chacko John, Prem Venkatachalam Pavoor, Sathya Narayanan and others.